Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...
A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone ...
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...
Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...
About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.
Following the successful launch of its GLP Compass (â„¢), Digbi Health continues to innovate by expanding its obesity test capabilities in 2025. These enhancements guide care providers and benefit ...
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Patients with metabolic dysfunction-associated steotohepatitis (MASH) who are already taking a glucagon-like peptide-1 ...